ARLG is changing the field of clinical research in antimicrobial resistance. We will talk with the Principal Investigators of the ARLG to discuss their strategy

Objectives:

• Review the history and accomplishments of ARLG
• Discuss the missions of ARLG including training new clinical investigators focused on antibiotic resistance
• Comment of the future of ARLG and clinical research on antibiotic resistance

Joining me to talk about ARLG are the principal investigators of this ambitious effort:

• Dr. Vance Fowler: Professor of Medicine, Florence McAlister Distinguished Professor of Medicine, Professor in Molecular Genetics and Microbiology, Duke University.
• Dr. Henry “Chip” Chambers: Professor of Medicine, Emeritus. University of California, San Francisco

Visit aac.asm.org to read the current issue.